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Abstract The levels of six mRNAs coding for constituent a- 
chains of three minor collagens of cartilage were analyzed in an 
experimental fracture model in normal and transgenic Dell mice 
harboring a deletion mutation of exon 7 in the type II collagen 
gene. Reduced and retarded chondrogenesis in Dell mice was 
evident in callus samples as reduced mRNA levels for the car- 
tilage specific type IX and XI collagens at days 7 and 9 of 
fracture healing. Analysis of the calluses for alternative splicing 
of proal(II) collagen mRNA also suggested retarded chondro- 
genesis in Dell calluses. Another developmentally regulated step 
in limb development, a switch between alternative promoters of 
the al( IX) collagen gene, was also seen during fracture healing 
but was less obvious in Dell calluses. Finally, the current data 
suggest that the abnormality in bone remodelling in Dell mice 
involves activation of the genes coding for al(XI) and a2(VI) 
collagens. 
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I. Introduction 
Healing of a fractured bone repeats in an adult organism 
several of the steps een during embryonic development of long 
bones by endochondral ossification [1]. Initially the fracture 
callus consists of undifferentiated mesenchyme which then un- 
dergoes partial chondrogenesis, and is finally replaced by bone. 
Under optimal conditions the healing process represents rue 
regeneration since bone remodelling results in complete resto- 
ration of bone architecture without a scar. We have previously 
followed the production of the different connective tissue ma- 
trices, mesenchyme, cartilage and bone, during fracture healing 
by determination f mRNA levels for the major fibrillar colla- 
gens, types III, II and I, respectively [2-4]. Furthermore we 
have shown that the mRNA for c~2(IX) collagen is coexpressed 
with the cartilage specific pro~l(II) collagen mRNA while the 
mRNA for ~I(X) collagen is expressed somewhat later as ex- 
pected for this hypertrophic chondrocyte specific collagen [5]. 
More recently we have shown that the mRNAs for the small 
proteoglycans, decorin, fibromodulin and biglycan are largely 
coexpressed with aggrecan, link protein and type II collagen 
mRNAs [6]. Furthermore the mRNA levels for decorin and 
biglycan were also increased uring the bone remodelling stage 
of fracture healing. 
*Corresponding author. Fax: (358) (21) 261 2284. 
As an alternative approach to analyze the relative roles of 
different tissue components in fracture callus we have analyzed 
the same complex gene expression patterns in transgenic Dell 
mice harboring a deletion mutation in the type II collagen gene 
which results in reduced and retarded chondrogenesis and 
structural weakening of cartilage [7]. We demonstrated de- 
creased levels of cartilage specific mRNAs in fracture callus 
tissue of Dell mice during the first and second week of healing 
[5]. These studies also revealed an unexplained abnormality in
bone remodelling in Dell mice resulting in osteopenia/osteopo- 
rosis particularly in the cancellous bone mass of metaphyses of
long bones [5]. Furthermore the mRNAs for decorin, biglycan, 
osteonectin and TGF-,81 were present in elevated amounts in 
callus tissue during bone remodelling [5,6]. 
Availability of new species specific cDNA probes for minor 
collagens made it possible to extend these gene expression stud- 
ies on fracture callus tissue of both normal and transgenic Del I 
mice. Clearly such information is needed for understanding the 
complex changes in the extracellular matrix during the fracture 
healing process. In this study we determined the mRNA levels 
for all three chains of type IX collagen, for the prowl chain of 
type XI collagen found in both cartilage and bone [8], and for 
the ~2 chain of type VI collagen, a ubiquitously expressed 
microfibrillar collagen [9]. We also analyzed the calluses for the 
presence of the alternatively processed/transcribed forms of 
proccl(II) and c~I(IX) collagen mRNAs. 
2. Materials and methods 
2.1. Experimental animals 
This study was performed on 33 heterozygous Dell transgenic mice 
and on their nontransgenic littermates (n= 43) used as controls. The 
animals were 10-12 weeks of age at the beginning of the study. The 
study protocol was reviewed and accepted by the institutional nimal 
care committee. 
2.2. Experimental model 
A closed iaphyseal fracture of the tibia was produced bilaterally in 
each animal under general anesthesia asdescribed earlier [10]. Briefly. 
a stainless-steel rod was first introduced into the intramedullary canal 
of each tibia. A fracture apparatus was then used to produce reproduc- 
ible fractures in the tibial bones. The animals were allowed unrestricted 
weight bearing in cages after ecovery from anesthesia. The animals 
were killed at 7, 9, 14 and 28 days postoperatively foranalysis of the 
fracture calluses. Unfractured iaphyseal bones of the nontransgenic 
animals were used for the isolation of control RNA. 
2.3. mRNA anal.vsis 
The fracture calluses of each group were pooled for isolation of total 
RNA at days 7, 9, 14, and 28 [11]. For Northern hybridizations, total 
RNAs were denatured with glyoxal and DMSO, fractionated on 0.75% 
agarose gels, and transferred by blotting to Pall Biodyne nylon mem- 
branes. The membranes were prehybridized and thereafter hvbridized 
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with the following cDNA probes: pMCol6~2 1 for mouse pro~2(VI) 
collagen (SS.~mS.nen and Vuorio, unpublished), pMCol9cd-I for mouse 
~I(IX) collagen [12], pMCol9~2 1 for mouse ~2(IX) collagen [13], 
pMCol9~3-1 for mouse ~3(IX) collagen (Per~ilfi and Vuorio, unpub- 
lished) and pMColllc~l 1 for mouse pro~l(XI) collagen (Per/ilfi and 
Vuorio, unpublished). Furthermore a cDNA clone pMC l2~l-2 con- 
taining the sequence of the alternatively spliced exon 2 of the mouse 
type II collagen gene was used [14]. Inserts were purified from each 
plasmid after appropriate restriction digests and labeled with [32p]dCTP 
to specific activities of approximately 10* cpm/mg using the random 
priming method. After hybridization, the filters were washed and the 
bound probe was detected by autoradiography and quantified by laser 
densitometry. These values were corrected for variation in totalRNA 
levels loaded on gels using values obtained by hybridization ofthe same 
filters with a probe for 28 S rRNA [15]. 
3. Results 
Total RNAs isolated from fracture callus tissue at four time 
points of healing were analyzed by Northern hybridization 
using a panel of mouse pecific cDNA probes (Fig. 1). All the 
probes have been constructed and tested for specificity in the 
authors' laboratory. The hybridization signals of several expo- 
sures of each filter were quantified by laser densitometry (Fig. 
2) and corrected for the variation in loading using the level of 
28 S rRNA as the reference (data not shown). For comparison 
the changes in type II collagen mRNAs reflecting the cartilag- 
inous phase of fracture healing in control and Dell mice are 
also shown in Fig. 2. When the same hybridization filter was 
analyzed with a probe containing only exon 2 sequences of the 
Co12c~1 transcript the pattern observed (Figs. 1A and 2C) was 
clearly different from total type II collagen mRNA. 
The three mRNAs for type IX collagen mRNAs exhibited 
very similar expression patters (Fig. 1). In all cases the mRNA 
levels in Dell mouse calluses were reduced when compared 
with the nontransgenic littermates (Fig. 2). Only low levels of 
the short form of the c~l(IX) collagen mRNA were observed in 
the sample isolated from the calluses of control animals at days 
7 and 9 (Fig. 1). 
The mRNAs for prowl (XI) and ~2(VI) collagen were present 
at all time points of fracture healing studied (Fig. 1). The levels 
of these two mRNAs varied considerably during the process 
and were low in unfractured bone (Fig. 2). A major difference 
between calluses of Dell and control animals was seen during 
bone remodelling at day 28: the mRNA levels of both 
pro~l(XI) and ~2(VI) collagen were markedly elevated in Dell 
mice. 
4. Discussion 
A 
Analysis of vertebrate limb development has lead to the iden- 
tification of families of regulatory genes whose ordered expres- 
sion forms complex patterns [16] in the limb mesenchyme prior 
to chondrogenesis and osteogenesis, .e. prior to the expression 
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Fig. 1. Northern analysis of callus tissue for mRNA levels of the long form of proc¢l (II) collagen (A), ~1 (IX) collagen (B), c~2(IX) collagen (C), c~3(IX) 
collagen (D), c~2(VI) collagen (E), and pro~l(XI) collagen (F). Total RNAs were isolated from callus tissue of normal (c) and transgenic Dell (t) 
mice at the time points indicated above each lane, and from unfractured bone (b). The arrow points the location of the short form of the cd(IX) 
collagen mRNA in panel B. Aliquots of 10 fig were fractionated on 0.75% agarose gels, transferred by blotting on o Pall Biodyne hybridization 
membranes, and hybridized with 32p-labelled probes. 
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Fig. 2. Quantitation ofmRNA levels of the procO(II) collagen (A, from ref. 5), ~I(IX) collagen (B), the long form of procd(lI) collagen (C), ~x2(IX) 
collagen (D), ~2(VI) collagen (E), cz3(IX) collagen (F), pro0d(XI) collagen (G), in fracture calluses of normal (black bars) and transgenic Dell mice 
(hatched bars) at days shown below the bars. The mRNA levels are given as relative densitometric units, b, unfractured bone. 
of genes specific for these tissues. As many of the steps seen 
during the limb morphogenesis are repeated in an adult organ- 
ism during the healing of fractured bones [1] it is conceivable 
that the different families of transcription factors (e.g. Hox- 
genes and retinoid receptor genes) and signalling molecules 
(e.g. bone morphogenetic proteins and fibroblast growth fac- 
tors and their receptors) which apparently regulate morpho- 
genesis and pattern specification during limb development [16] 
are also expressed uring fracture healing. However, it is not 
known how far back in limb organogenesis dedifferentiation 
goes before initiation of chondrogenesis during fracture heal- 
ing. Except for some growth factors, little is known about the 
production or effects of these factors during fracture healing 
[17]. We have been studying the gene expression patterns in the 
murine fracture callus tissue initially by determining the levels 
of the most abundant mRNAs for the major fibrillar collagens, 
and proceeded towards less abundant messages [4,5]. In the 
present study we have focused our interest on minor col- 
lagenous components of cartilage matrix and on alternatively 
processed variants of type II and type IX collagens which have 
been associated with early steps of chondrogenesis. 
The expression of type II collagen gene has been shown to 
undergo an alternative splicing step of exon 2 coding for a 
globular domain in the amino-terminal propeptide [14,18]. The 
longer form of the mRNA is clearly related to prechondrogenic 
tissue and the short form to mature cartilage [19]. The gene for 
the ~1 chain of type IX collagen has two alternative promoters 
[20]. Expression of the short form of the cd(IX) mRNA, but 
not of the protein, has been detected early in developing limb 
buds in nonchondrogenic regions while the long form of the 
mRNA and the protein colocalize with type II collagen and its 
mRNA [21]. Our results demonstrate he presence of the long 
form of type I! collagen mRNA typical for prechondrogenic 
tissue in fracture callus tissue at days 7 and 9. This shows that 
the mechanism of de novo chondrogenesis in callus repeats the 
same steps as during limb chondrogenesis. The results also 
reveal a difference between Dell mice and the controls: in the 
latter the expression of the long form of pro~l(II) collagen 
mRNA peaks at day 7 and in the former at day 9. This is in 
agreement with our earlier claims of retarded chondrogenesis 
in Del 1 mice [5-7]. A somewhat different picture was seen with 
the processing variants of type IX collagen: low levels of the 
short (prechondrogenic) form of ~I(IX) collagen mRNA were 
seen in control calluses at days 7 and 9, but none was detectable 
in the Dell samples. This may be explained by a detection 
problem due to lower overall evels of type IX collagen mRNAs 
in Dell calluses. It is also possible that some differences exist 
in the activation of prechondrogenic mesenchyme between 
Dell and control mice. Differential expression of type II and 
type IX collagen transcripts has been detected in other chon- 
drogenic and nonchondrogenic regions of developing embryos 
[22]. The expression profiles of the mRNAs coding for the ~1, 
~2, and ~3 chains of type IX collagen were quite similar sug- 
gesting that the homotrimeric nature of this collagen type is 
maintained throughout chondrogenesis both in normal and 
transgenic Dell calluses. 
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Type XI collagen mRNA was not only present during the 
cartilaginous phase of callus healing, but was also activated 
during bone remodelling stage at day 28 when no other mRNAs 
for cartilage collagens are present. This is in agreement with 
earlier data of the prowl (XI) chain being able to associate with 
type V collagen chains in bone [8,23]. We have previously dem- 
onstrated by histomorphometry that the volume of the cartilag- 
inous component in the fracture calluses of Dell mice is mark- 
edly reduced when compared with the control mice [5]. The 
present data on reduced levels of mRNAs for cartilage colla- 
gens of types IX and XI confirms the earlier data and extentend 
the list of mRNAs which are reduced in fracture calluses of 
Dell mice. 
No previous data is available on the production of type VI 
collagen in fracture callus tissue. The present findings on the 
continuous presence of ~2(VI) collagen mRNA in callus sug- 
gest that this collagen type is produced throughout the fracture 
healing process which is in accordance with the suggested ubiq- 
uitous expression of type VI collagen in a class of microfibrils 
[9]. The presence of type VI collagen in cartilage is well docu- 
mented but the levels have been suggested to be low in bone 
[24]. Interestingly the highest level of ~2(VI) collagen mRNA 
in the present series was observed in day 28 calluses of Dell 
mice. The difference between transgenic Dell mice and their 
nontransgenic littermates during the bone remodelling stage is 
analogous to our recent observation of elevated mRNA levels 
for decorin, biglycan and TGF-fll in Dell mice at this time 
point [6]. Major differences in the remodelling of cancellous 
bone have been observed between Dell mice and their non- 
transgenic littermates [5]. However, we have no explanation 
how the deletion mutation in type II collagen transgene in the 
Dell mice [7] results in this abnormality. Since decorin has been 
shown to associate with type VI collagen [25] it is possible that 
some elements of this widespread derangement of gene expres- 
sion are interconnected. The present data also suggests that 
microfibrils may be somehow involved in the remodelling proc- 
ess of bone. Further studies on bone remodelling in Dell mice 
may help elucidate underlying mechanism in osteopenia nd 
osteoporosis. 
In conclusion, the present results extend our knowledge 
about the changes in the expression of collagen genes during 
fracture healing. They confirm that chondrogenesis in the un- 
differentiated mesenchyme of fracture callus shares imilarities 
with that in the limb mesenchyme. At least the alternative 
splicing of type II collagen exhibited a pattern typical for pre- 
chondrogenic mesenchyme both in normal and transgenic Dell 
calluses. Thus the type II collagen mutation in Dell mice does 
not seem to disturb the regulation of the alternative splicing. 
However, based on the current data a switch of alternative 
promoters of the ~I(IX) collagen gene during fracture healing 
is less obvious in calluses of Dell mice than in control calluses. 
Finally the current data suggest that the abnormality in bone 
remodelling in Dell mice also involves the genes coding for 
~I(XI) and ~2(VI) collagens. 
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